Alopecia Areata-Like Presentations With Mogamulizumab Therapy

    September 2023 in “ JAAD case reports ”
    Colin M. Kincaid, Ajay Sharma, Bonnie Lee … Natasha Atanaskova Mesinkovska
    Studysummary In this case report, mogamulizumab treatment for Sézary syndrome was associated with rashes and alopecia in a patient, highlighting the potential for immune-mediated side effects and suggesting that such adverse effects might indicate a favorable prognosis, though further studies are needed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaadcasereports.org →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Alopecia Areata After Mogamulizumab Treatment JAAD Case Reports · 2021
    2. The Role of Lymphocytes in the Development and Treatment of Alopecia Areata Expert Review of Clinical Immunology · 2015

    Related research 1

    1. Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child International journal of research in dermatology · 2019